ArticleAdvanced healthcare materials2017

Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr

Mikyung Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.